A Direct Aspiration First Pass Technique in Japanese Real-World Clinical Setting

医学 改良兰金量表 半影 蛛网膜下腔出血 优势比 脑出血 置信区间 冲程(发动机) 溶栓 外科 人口 回顾性队列研究 内科学 缺血性中风 心肌梗塞 缺血 工程类 环境卫生 机械工程
作者
Junji Uno,Katsuharu Kameda,Ryosuke Otsuji,Nice Ren,Shintaro Nagaoka,Kazushi Maeda,Yoshiaki Ikai,Hidefuku Gi
出处
期刊:Operative Neurosurgery [Oxford University Press]
卷期号:17 (2): 115-122 被引量:2
标识
DOI:10.1093/ons/opy349
摘要

It is debatable whether mechanical thrombectomy has benefits in a real-world setting outside the more rigid and selective clinical trial environment.To evaluate clinical outcomes, efficacy, and safety of mechanical thrombectomy in single-center retrospective cohort case series.We reviewed prospectively collected data from our large-vessel occlusion stroke database to identify patients undergoing mechanical thrombectomy using Penumbra catheters (Penumbra, Almeida, California) as first-line devices. The primary outcomes were the modified Rankin Scale score at 90 d and recanalization rate. The secondary outcomes included the rates of hemorrhagic complications and mortality.The entire study population included 298 patients. Thrombolysis in Cerebral Infarction Scale ≥2b was achieved in 86.6% of patients. Fifty-five patients (18.5%) were outside the 6 hr time window and 82 patients (27.5%) were over 80-yr old. The posterior circulation thrombectomy rate was 12.4%. At 90 d from onset, 49.3% of patients had favorable outcomes. The parenchymal hemorrhage type 2 (PH2) and subarachnoid hemorrhage rates were 2.3% and 11.7%, respectively. In multivariate analyses, cerebral blood flow/cerebral blood volume mismatch (odds ratio [OR] = 9.418; 95% confidence interval [CI], 3.680-27.726; P < .0001), onset to recanalization time (OR = 0.995; 95% CI, 0.991-0.998; P = .0003), and hemorrhagic complications including PH2 and subarachnoid hemorrhage (OR = 0.186; 95% CI, 0.070-0.455; P = .0002) were associated with favorable outcomes.A direct aspiration first pass technique with an adjunctive device demonstrated high recanalization rates in old Japanese patients. Our patient cohort may reflect the application of endovascular techniques in acute ischemic stroke treatment in a real-world setting.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
建议保存本图,每天支付宝扫一扫(相册选取)领红包
实时播报
俊秀的思山完成签到,获得积分10
3秒前
呆萌的蚂蚁完成签到 ,获得积分10
5秒前
xh完成签到 ,获得积分10
7秒前
pass完成签到 ,获得积分10
10秒前
NexusExplorer应助mark采纳,获得10
11秒前
racill完成签到 ,获得积分10
12秒前
唐唐完成签到,获得积分10
14秒前
T_MC郭完成签到,获得积分10
14秒前
16秒前
明郑敏完成签到 ,获得积分10
19秒前
陶醉觅夏发布了新的文献求助100
19秒前
19秒前
GPTea应助风清扬采纳,获得50
21秒前
张豪杰完成签到 ,获得积分10
27秒前
细心的安双完成签到 ,获得积分10
30秒前
十一完成签到,获得积分10
31秒前
evak完成签到 ,获得积分10
40秒前
先锋老刘001完成签到,获得积分10
40秒前
冷傲凝琴完成签到,获得积分10
42秒前
小二郎应助科研通管家采纳,获得20
50秒前
正己化人应助科研通管家采纳,获得10
50秒前
浮游应助科研通管家采纳,获得10
50秒前
赘婿应助科研通管家采纳,获得10
50秒前
寻找组织应助科研通管家采纳,获得30
50秒前
无心客应助科研通管家采纳,获得10
51秒前
浮游应助科研通管家采纳,获得10
51秒前
正己化人应助科研通管家采纳,获得10
51秒前
英姑应助科研通管家采纳,获得10
51秒前
ding应助科研通管家采纳,获得10
51秒前
无心客应助科研通管家采纳,获得10
51秒前
momo应助科研通管家采纳,获得10
51秒前
云洲完成签到,获得积分10
51秒前
正己化人应助科研通管家采纳,获得10
51秒前
不倦应助科研通管家采纳,获得10
51秒前
51秒前
情怀应助温暖的夏波采纳,获得10
53秒前
韩寒完成签到 ,获得积分10
53秒前
胡萝卜完成签到 ,获得积分10
56秒前
1分钟前
lchenbio完成签到,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
List of 1,091 Public Pension Profiles by Region 1541
Binary Alloy Phase Diagrams, 2nd Edition 600
Atlas of Liver Pathology: A Pattern-Based Approach 500
A Technologist’s Guide to Performing Sleep Studies 500
Latent Class and Latent Transition Analysis: With Applications in the Social, Behavioral, and Health Sciences 500
Using Genomics to Understand How Invaders May Adapt: A Marine Perspective 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5498637
求助须知:如何正确求助?哪些是违规求助? 4595826
关于积分的说明 14449838
捐赠科研通 4528777
什么是DOI,文献DOI怎么找? 2481732
邀请新用户注册赠送积分活动 1465732
关于科研通互助平台的介绍 1438561